tetradecanoylphorbol acetate has been researched along with 2,2'-(hydroxynitrosohydrazono)bis-ethanamine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bosmann, M; Chang, JH; Hellmuth, M; Huwiler, A; Mühl, H; Ninic, R; Nold, M; Paulukat, J; Pfeilschifter, J | 1 |
| Gerlach, RF; Izidoro-Toledo, T; Meschiari, CA; Tanus-Santos, JE | 1 |
2 other study(ies) available for tetradecanoylphorbol acetate and 2,2'-(hydroxynitrosohydrazono)bis-ethanamine
| Article | Year |
|---|---|
Nitric oxide augments release of chemokines from monocytic U937 cells: modulation by anti-inflammatory pathways.
Topics: Chemokine CCL4; Chemokines; Cyclic AMP; Dexamethasone; Enzyme Inhibitors; Genistein; Humans; Imidazoles; Inflammation; Interleukin-8; Macrophage Inflammatory Proteins; Mitogen-Activated Protein Kinases; Monocytes; Nitric Oxide; Nitric Oxide Donors; p38 Mitogen-Activated Protein Kinases; Protein-Tyrosine Kinases; Pyridines; Signal Transduction; Tetradecanoylphorbol Acetate; Transforming Growth Factor beta; Triazenes; U937 Cells | 2000 |
Nitric oxide attenuates matrix metalloproteinase-9 production by endothelial cells independent of cGMP- or NFκB-mediated mechanisms.
Topics: Cells, Cultured; Culture Media, Conditioned; Cyclic GMP; Enzyme Repression; Gene Expression; Human Umbilical Vein Endothelial Cells; Humans; Matrix Metalloproteinase 9; Nitric Oxide; Nitric Oxide Donors; Nitriles; Nitroso Compounds; Phosphorylation; Protein Processing, Post-Translational; Sulfones; Tetradecanoylphorbol Acetate; Tissue Inhibitor of Metalloproteinase-1; Transcription Factor RelA; Transcription, Genetic | 2013 |